Jeffrey Hafkin
Company: Otsuka
Job title: Senior Director
Seminars:
Rational for Targeting APRIL in IgA Nephropathy 1:45 pm
Providing an overview of the Sibeprenlimab development program Reviewing the latest data from the phase 2 trial Optimizing trial design for the phase 3 program: The Visionary Trial DesignRead more
day: Pre-Conference Seminar Day